IFOND Dictionary: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z NUM Index
 |
International Foundation for Optic
Nerve Disease |
If you find this site helpful or IFOND sponsored research worthwhile, please donate to IFOND at the address above,
or JustGive.org.
Using This Site |
| IFOND NEWS |
|---|
|
IFOND gratefully acknowledges all our generous donors. For years a large portion of our funding has been from the IFOND annual golf outing. This happy event will continue. Email us if you are attending. Recently we have also been getting a steady but modest flow of online donations from many sources. McCORMICK& COMPANY, INC. have been generous regular donors with their Matching Gifts Program. In July 2010 we were graced with a large donation from The Welcoming Club of Garden City. See our fundraising section for further details and recognition. Without your generous giving our important research would not happen. Alfredo A. Sadun, MD, PhD, wins 2012 William F. Hoyt Award The IFOND Board is very proud to have Professor Aldredo Sadun as a scientific advisor. This November our most distinguished and effective teacher, clinician and researcher was awarded by the American Academy of Ophthalomology and the North American Neuro-Ophthalmology Society their highest honour in Neuro-Ophthalmology, The William F. Hoyt Lecturer Award. 17th Annual Golf Outing success Don Diehl, Golf Outing Chair, reports that the 17th Annual Golf Outing Fundraising Event held on September,10 2012 was a resounding success with over 125 golfers participating and many other generous sponsors and donors contributing to the effort. Idebenone treatment for LHON A randomized placebo controlled study published in the journal Brain showed idebenone to be an effective treatment for LHON. Idebenone is a synthetic benzoquinone, co-enzyme Q10 like substance, potent antioxidant and inhibitor of lipid peroxidation, which also interacts with the mitochondrial electron transport chain and facilitates mitochondrial electron flux through by-passing complex I. It was shown in the study to be well tolerated and have modest effectiveness in about half of LHON patients treated. The result confirms retrospective treatment data soon to be published. People treated early in onset and for prolonged periods were likely to benefit most. LHON treatment trials IFOND scientific members are involved in new LHON treatment trials using the Vitamin E metabolite substance, Alpha-tocotrienol-quinone, coded EPI-743, a potent antioxidant. Find Dr Jerry Sherman's presentation of his optometric case findings in this promising open label study in Review of Optometry Case 38 Leber's Hereditary Optic Neuropathy [Note: be patient for the 60 second wait to download the 100 slides.] Brazil LHON Field Trip Reports With your support, IFOND sponsors research on the world's largest Leber Hereditary Optic Neuropathy [LHON] pedigree. In our projects section Dr Alfredo Sadun, the study co-ordinator, has summarized the studies to date since 2001 when they began with IFOND sponsorship. We have pushed the frontiers of knowledge about Leber Hereditary Optic Neuropathy. Please donate to IFOND to see this and other worthwhile IFOND work continue. |
This site is designed for ease of reading and navigation for those with various visual capabilities. We strive to make it as accessible as possible for all. We hope you find it useful.
Browsers
The site can be used with most Web browsers e.g. Firefox, Opera, Konqueror, Safari, Internet Explorer, etc on most operating systems which the browser supports. We highly recommend the most up to date browsers for security, readability and ease of use. Most browsers can be freely downloaded on the internet.
Font style and size
The default text fonts were selected for simplicity and ease of reading. It is possible to change the size of the fonts on most browsers. Firefox and Konqueror also allow a font style and size override. In Firefox these changes are accessed through the Edit (or Tools) - Preferences menu. In Internet Explorer use View - Text size. In Konqueror use Settings - Configure - Browser - Appearance or the magnifying icon.
Page sizing and printing.
The pages were designed to be flexible in window size using the whole window and minimizing horizontal scrolling. This should make good viewing on most screen resolutions and allow custom printing.
Navigation
The site has hyperlinks to other sections within it as well as to outside sources around the Internet World Wide Web.
Frames, an unfortunate HTML element, were avoided in the design of the site. They complicate linking to and from parts of the site. They consume screen space when it is at a premium with large font viewing.
Copying.
We wish to promote spread of this information through as many channels as possible. We intend the IFOND Web site to be easily copied and reused. However, we do wish to retain copyright on the IFOND Web page documents, and would like to be notified of any plans to redistribute them.
Unless otherwise stated, for example in IFOND article reprints, IFOND Web pages are copyrighted by IFOND or their respective authors. IFOND Web pages may be reproduced and distributed in whole or in part, in any medium physical or electronic, as long as this copyright notice is retained on all copies. Commercial redistribution is allowed and encouraged. However, IFOND would like to be notified of any such distributions.
All translations, derivative works, or aggregate works incorporating any IFOND Web page document must be covered under this copyright notice. That is, you may not produce a derivative work from an IFOND document and impose additional restrictions on its distribution. Exceptions to these rules may be granted under certain conditions; please contact IFOND.
If you have questions, please contact IFOND by email at ifond@aol.com..
See your doctor
Please take note of the disclaimer at the bottom of each page, especially the part which says see your own doctor for advice.
Enjoy!
Enjoy using the IFOND site. There is a lot to see. If you have contributions or additions, comments or suggestions regarding the site design or about anything related to IFOND please contact us. We welcome your participation in this project.
About IFOND | Projects | Understanding OND | Ischaemic OND | Toxic OND | Glaucomatous OND | Leber Hereditary Optic Neuropathy | Support for the Blind | References/Links | Image Gallery | Fundraising | Feedback | Using this site | HOME
If you find this site helpful or IFOND sponsored research worthwhile, please donate to IFOND at the address below,
or JustGive.org.
The International Foundation for
Optic Nerve Disease
P. O. Box 777, Cornwall NY 12518, USA.
TEL/FAX (845) 534 7250
Email: ifond@aol.com
Web site:
http://www.ifond.org/
IFOND is registered service mark of
The International Foundation for Optic Nerve Disease
Copyright 1999-2013, International Foundation for
Optic Nerve Disease.
The information contained on this website should not be considered medical guidance or professional advice. IFOND is not responsible for errors or omissions in information provided on this site or actions resulting from its use. IFOND does not publish all information from all available sources on optic nerve disease. IFOND is not responsible for the validity of the studies or reviews nor is it an advocate of studies or reviews mentioned on or linked from the IFOND web site. IFOND does not endorse or recommend participation in any particular clinical trial or treatment protocol which may be mentioned on this site. Direct any questions concerning your personal health to your appropriate health care professional.